End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20,050 KRW | +0.80% | +3.62% | -4.52% |
2023 | Tranche Update on Macrogen, Inc.'s Equity Buyback Plan announced on October 21, 2022. | CI |
2023 | Tranche Update on Macrogen, Inc.'s Equity Buyback Plan announced on October 21, 2022. | CI |
Chart calendar Macrogen, Inc.
Upcoming events on Macrogen, Inc.
Past events on Macrogen, Inc.
2024-03-31 | Q4 2023 Earnings Release (Projected) |
2023-11-13 | Q3 2023 Earnings Release |
2023-05-14 | Q1 2023 Earnings Release |
2023-03-22 | Q4 2022 Earnings Release |
2022-11-13 | Q3 2022 Earnings Release |
2022-08-15 | Interim 2022 Earnings Release |
2022-05-15 | Q1 2022 Earnings Release |
2021-08-16 | Interim 2021 Earnings Release |
2021-05-16 | Q1 2021 Earnings Release |
2021-03-22 | FY 2020 Earnings Release |
2020-03-29 | FY 2019 Earnings Release |
2019-11-13 | Q3 2019 Earnings Release |
2019-05-14 | Q1 2019 Earnings Release |
2019-04-24 | International Society for Extracellular Vesicles Meeting |
2018-08-13 | Interim 2018 Earnings Release |
2018-02-07 | FY 2017 Earnings Release |
Past dividends on Macrogen, Inc.
2023-12-26 | Annual 300 KRW |
2022-12-27 | Annual 300 KRW |
2021-12-28 | Annual 300 KRW |
2020-12-28 | Annual 300 KRW |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 0,00 | 139 136 1.92% | 133 130 2.08% | 148 |
EBITDA Billions KRW | Released Forecast Spread | 0,00 | 16,0 17,0 -6.11% | 7,13 9,00 -20.77% | 23,0 |
EBIT Billions KRW | Released Forecast Spread | 0,00 | 5,29 9,00 -41.19% | -0,50 -1,80 72.04% | 11,0 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 | -25,9 10,0 -359.45% | -8,27 -3,00 -175.7% | 12,0 |
Net income Billions KRW | Released Forecast Spread | 1,11 | -20,0 9,00 -322.37% | -6,88 -3,10 -121.9% | 10,3 |
EPS KRW | Released Forecast Spread | 114 | -1 990 859 -331.66% | -1 683 -288 -484.38% | 947 |
Announcement Date | 23/03/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 29,7 37,1 -19.84% | 35,5 33,9 4.86% | 38,0 36,6 3.94% | 36,9 34,2 7.96% | ||
EBIT Billions KRW | Released Forecast Spread | 0,64 4,00 -84.03% | 0,12 1,20 -89.83% | 1,63 4,10 -60.21% | 1,57 0,20 686.65% | ||
Net income Billions KRW | Released Forecast Spread | 0,16 | -4,99 4,00 -224.86% | -1,98 | -13,5 0,40 -3469.81% | ||
EPS KRW | Released Forecast Spread | 50,0 | -198 | ||||
Announcement Date | 16/05/22 | 16/08/22 | 14/11/22 | 16/02/23 | 14/11/23 | 15/02/24 |
Past sector events for Macrogen, Inc.
2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A038290 Stock
- Calendar Macrogen, Inc.